Biotoxtech (086040) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, Biotoxtech (086040) reported revenue of 47.0 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
202547.0 billion KRW-4.8 billion KRW-1.6 billion KRW[source]
202441.3 billion KRW-8.9 billion KRW-12.7 billion KRW[source]
202332.6 billion KRW-8.2 billion KRW-9.0 billion KRW[source]
202237.3 billion KRW800 million KRW1.5 billion KRW[source]
202134.1 billion KRW4.2 billion KRW7.0 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
202595.0 billion KRW41.1 billion KRW53.9 billion KRW[source]
202492.8 billion KRW41.4 billion KRW51.4 billion KRW[source]
202392.4 billion KRW37.7 billion KRW54.6 billion KRW[source]
202294.3 billion KRW50.0 billion KRW44.3 billion KRW[source]
202188.3 billion KRW48.0 billion KRW40.3 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice